TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.

Manmeet S Ahluwalia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.